Finished
Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT: (the RELIANT Trial)
NCT05705544 · Vanderbilt University Medical Center · Updated 24 April 2025
- What is being tested
- ILLUMISITE™ Platform (EMN bronchoscopy); Ion™ Endoluminal System (SSCB bronchoscopy)
- For
- Peripheral Pulmonary Lesions
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 447 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 6 March 2023, ends 9 April 2024. Registered 30 Jan 2023.
- Results
- Posted on the registry on 24 April 2025.
In the researchers' words
This is an investigator-initiated, cluster randomized controlled trial. The primary objective is to compare the diagnostic yield of the Ion™ Endoluminal System (SSCB) to the ILLUMISITE™ Platform (EMN bronchoscopy) in patients undergoing bronchoscopy for peripheral pulmonary lesion (PPL) evaluation.
Sites
- Vanderbilt University Medical CenterNashville, Tennessee, United States